Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide

Paola Papaldo, Massimo Lopez, Paolo Marolla, Enrico Cortesi, Mauro Antimi, Edmondo Terzoli, Patrizia Vici, Carlo Barone, Gianluigi Ferretti, Serena Di Cosimo, Paolo Carlini, Cecilia Nisticò, Francesca Conti, Luigi Di Lauro, Claudio Botti, Francox Di Filippo, Alessandra Fabi, Diana Giannarelli, Federico Calabresi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide'. Together they form a unique fingerprint.

Medicine & Life Sciences